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Trends in Bacteremic Infection Due to Streptococcus
pyogenes (Group A Streptococcus), 1986-1995
During the past 7 years, severe invasive infec-
tions caused by Streptococcus pyogenes (group A
streptococcus [GAS]) have been reported with in-
creasing frequency (1). It is not certain whether
these reports reflect actual increase in the inci-
dence of disease caused by this pathogenic bacte-
rium or merely enhanced awareness and interest
on the part of the medical community. This diffi-
culty prevails whether the apparent resurgence of
life-threatening infection is described within a
region (2), a province (3), or in discrete outbreaks
(4,5) and is heightened by the fact that streptococ-
cal infection has not been a reportable disease in
most locales.
An outbreak of infection may awaken interest
in streptococcal disease, leading to publication
bias (6,7). Continued study may show that what
appears to be a general increase in the incidence
of GAS infection may actually represent an out-
break, as has been demonstrated in Colorado (8,9),
Sweden (10), and the United Kingdom (11). In a
laboratory-based study, Burkert and Watanaku-
nakorn (12) found that the frequency and appar-
ent severity of bacteremic infection due to S.
pyogenes did not change from 1980 to 1989. A
meticulous, population-based study in Pima
County, Arizona (13), found no change in the inci-
dence of invasive GAS disease between 1985 and
1990 but did suggest the emergence of streptococ-
cal toxic shock syndrome in the late 1980s, on the
basis of the appearance of six such cases in 1987-
1990 compared to zero cases in 1985-1987. In
contrast, a preliminary, population-based report
from Israel (14) found no such increase.
The Houston Veterans Affairs Medical Center
(HVAMC) serves about 50,000 eligible veterans,
most in Harris County, Texas, and surrounding
counties, although a small number of these veter-
ans live elsewhere in Texas or in bordering states.
Most patients are middle-aged or elderly men,
although approximately 20% are under the age of
40. Within the past decade, there have been
broader medical options for some of our patients,
especially those who are indigent and/or elderly,
and narrower options for others, especially those
whose medical insurance was initially marginal.
Nevertheless, most persons who select the
HVAMC for care of any problem tend to identify
themselves with this medical center and look to it
to provide complete medical care (15).
In contrast to that reported by some medical
centers in the United States, our clinical experi-
ence did not suggest that the number or severity
of infections due to S. pyogenes had increased
during the past decade. Because our population
was relatively stable and data were available in
our Microbiology Laboratory for 1986 through
1995, we studied trends in bacteremic infection at
the medical center during this period.
In the 9 years under study, the number of yearly
inpatient admissions to the HVAMC decreased by
4.1%, while the number of outpatient visits in-
creased by 33.9%. The number of patients who, in
a given year, sought medical attention at the cen-
ter (determined by social security numbers), in-
creased by 18.7%, with a 5.2% decrease in those
persons admitted to the hospital and a 19.4%
increase in those who sought outpatient care. Dur-
ing this period, the number of blood specimens
submitted for cultures each year remained essen-
tially unchanged. We have noted no change in the
clinical findings that prompt interns and residents
to request blood cultures, although the possibility
of unrecognized, subtle changes cannot be ex-
cluded.
The rate of isolation of GAS from blood cultures
(Figure 1) or from all sterile sites (data not shown)
remained unchanged between 1986 and 1995. The
number of positive blood cultures tended to be
lower in the summer and early fall and to rise in
midwinter, but the average number has remained
at approximately five to eight per year during the
entire decade. The frequency with which GAS
were isolated from all specimens declined signifi-
cantly (p = 0.003) during the decade under obser-
vation.
These data suggest that the frequency of bac-
teremic infection due to S. pyogenes has not in-
creased in a population of veterans residing in and
around Houston, Texas. The number of isolates of
S. pyogenes from blood and from all sterile sites
has remained unchanged, whereas the number of
persons served in inpatient and outpatient en-
counters actually increased. The slight, but sig-
nificant decrease in the total number of isolates
from all sources might suggest that an
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an increased prevalence of virulent strains, but
the large number of variables involved in collect-
ing all specimens makes these data difficult to
interpret.
By showing that the incidence of S. pyogenes
bacteremia has not changed, these results appear
to support our anecdotal observation that the in-
cidence of life-threatening GAS infection has not
increased. Without reviewing every single case,
which is best done prospectively rather than
retrospectively, we cannot exclude the possibility
that the number of cases associated with strepto-
coccal shock syndrome has increased, as was sug-
gested in Pima County (13). Even that study,
however, showed only six cases of shock (two per
year) in 1987 through 1990 compared to none in
1985 through 1987; one wonders whether bias in
recording data might have been partially
responsible, and whether this increase will per-
sist. We also do not know what proportion of our
cases is associated with necrotizing fasciitis, al-
though it must be noted that Hoge, et al. (13)
specifically did not document the association be-
tween this clinical syndrome and streptococcal
toxic shock. Our findings cannot exclude the pos-
sibility that serious GAS has increased in younger
adults, as has been reported
by others (1,13), since our
population tends to be (but is
not exclusively) middle-aged
or older. Also, the effect of
increases may not have been
observed in Houston. In any
case, reporting bias is diffi-
cult to avoid, and prospective
population-based studies
must be carried out over an
adequate number of years be-
fore they can provide valid
conclusions.
If the frequency of severe
GAS infection has, in fact, in-
creased, a virulent clone or
the mutation of a clone that
has antigens to which most
adults lack antibody could be
responsible. Serotype M1 has
predominated in reports of
streptococcal toxic shock syn-
drome (16-18). Some investi-
gators (19) have proposed that allelic variation in
the streptococcal pyrogenic exotoxin A gene (speA)
may contribute to disease severity; however, oth-
ers have not found a high prevalence of isolates
that produce pyrogenic exotoxin A among organ-
isms that cause streptococcal toxic shock syn-
drome. Although the gene that encodes pyrogenic
exotoxin B, a cysteine protease, has been univer-
sally present in virulent isolates, this gene is also
present in nearly all other GAS isolates; therefore,
its importance in toxic shock-producing strains
remains unclear. Finally, changes in herd immu-
nity to certain exotoxin B variants and/or M pro-
tein serotypes may result in an increased
susceptibility to newly emerging mutant strains
(20).
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Figure 1. The bars show the number of isolates of Streptococcus pyogenes (GAS)
each month at the VAMC, Houston. The upper line connecting solid squares
indicates the running monthly average (average of the preceding 12 months).
The lower line connecting solid circles indicates the number of blood cultures
positive for S. pyogenes during each 6-month period.
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